# 68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies

> **NCT05515783** · PHASE1,PHASE2 · UNKNOWN · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Tumor

## Interventions

- **DRUG:** 68Ga-FAP-RGD
- **DRUG:** 68Ga-FAP-RGD

## Key facts

- **NCT ID:** NCT05515783
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05515783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05515783, "68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05515783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*